CDK4 and melanoma: As shown in Figure 4(b), AC treatment (40–120 μg/mL) for 24 h caused a dose-dependent reduction of cyclin D1 and its up-stream kinase, CDK4, in both B16F10 and B16F1 melanoma cells.